CVRx director granted stock and options

CVRx, Inc. director Mitch C. Hill received equity compensation in the form of common shares and stock options.

Rhea-AI Filing Summary

CVRx, Inc. director Mitch C. Hill received equity compensation in the form of common shares and stock options. He was granted 8,720 shares of Common Stock at no cost, leaving him with 8,720 common shares held directly after the award. He also received a stock option for 11,182 shares of Common Stock at an exercise price of $5.43 per share, expiring on June 1, 2036. According to the footnote, this award vests on the earlier of June 1, 2027 or the company’s 2027 annual meeting of stockholders, indicating a long-term, service-based incentive rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 19,902 shares

Grant/Award 2 txns

Insider Hill, Mitch C.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	11,182	$0.00	$0.00
Grant/Award	Common Stock	8,720	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 11,182 contracts (Direct); Common Stock — 8,720 shares (Direct)

Footnotes (1)

1. F1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

Key Figures

Common shares granted: 8,720 shares Common shares held after grant: 8,720 shares Option shares granted: 11,182 shares +3 more

6 metrics

Common shares granted 8,720 shares Equity grant of Common Stock to director on June 1, 2026

Common shares held after grant 8,720 shares Total directly held Common Stock following the transaction

Option shares granted 11,182 shares Stock Option (right to buy) granted on June 1, 2026

Option exercise price $5.43 per share Conversion or exercise price of stock option

Option expiration June 1, 2036 Expiration date of stock option grant

Vesting date trigger Earlier of June 1, 2027 or 2027 annual meeting Vesting condition for the equity award

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, exercise price, expiration date, +1 more

5 terms

Stock Option (right to buy) financial

"Stock Option (right to buy) with underlying security of Common Stock"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

exercise price financial

"conversion_or_exercise_price of 5.4300 per share for the option"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date of 2036-06-01T00:00:00.000Z for the stock option"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

annual meeting of stockholders financial

"Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CVRX director Mitch C. Hill receive in this Form 4 filing?

Mitch C. Hill received equity compensation consisting of 8,720 shares of CVRx common stock and a stock option for 11,182 shares. Both awards were reported as grants, not open-market transactions, and are held directly in his name.

How many CVRX common shares were granted to Mitch C. Hill?

He was granted 8,720 shares of CVRx common stock. These were reported at a price of $0.00 per share, reflecting a compensation grant, and brought his directly held common stock position to 8,720 shares following the transaction.

What are the key terms of Mitch C. Hill’s CVRX stock option grant?

He received a stock option covering 11,182 shares of CVRx common stock at an exercise price of $5.43 per share. The option expires on June 1, 2036, providing a long-term potential ownership opportunity if exercised in the future.

When do Mitch C. Hill’s CVRX equity awards vest?

The equity award vests on the earlier of June 1, 2027 or CVRx’s 2027 annual meeting of stockholders. This vesting schedule links the compensation to continued board service over multiple years rather than immediate ownership.

Are Mitch C. Hill’s CVRX transactions open-market buys or sells?

No, both reported transactions are grants classified as "Grant, award, or other acquisition" under code A. They represent compensation awards of common stock and options, not open-market purchases or sales of CVRx shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 06:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hill, Mitch C.

(Last) (First) (Middle)

9201 WEST BROADWAY AVENUE

SUITE 650

(Street)

MINNEAPOLIS MINNESOTA 55445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		8,720(1)	A	$0	8,720	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.43	06/01/2026		A		11,182		(1)	06/01/2036	Common Stock	11,182	$0	11,182	D

Explanation of Responses:

1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

	/s/ Amy C. Seidel, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)